Skip to main content
Quest Diagnostics Home

Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care

Date: Friday, May 7, 2021

Description: A discussion and overview of the monoclonal antibody therapy program sponsored by the US Department of Health and Human Services.

Authors: 

Anderson, Michael R., MD, MBA, FAAP
Senior Advisor, Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services 

Chuk, Meredith, MD, FAAP
Lead, COVID-19 Therapeutics Team Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services 

Dugan, Vivien, PhD
Lead, Strain Surveillance and Emerging Variants Team, Laboratory & Testing Task Force, COVID-19 Emergency Response Team CDC 

Edward, Adolphe, DrHA, MBA, MSHA
Chief Executive Officer,
El Centro Regional Medical Center
El Centro, CA 

Kapoor, Hema, MD SM, D(ABMM)
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey 

Ramers, Christian B., MD, MPH, AAHIVS
Chief, Population Health and Director, Graduate Medical Education Family Health Centers of San Diego 

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy   •   Terms   •   Cookie notice   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   DO NOT SELL MY PERSONAL INFORMATION

Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000- 2021 Quest Diagnostics Incorporated. All rights reserved.
Image content features models and is intended for illustrative purposes only.